13 June 2024 Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for ...

21 January 2025 New president says repeal is first of “many steps the US federal government will take to repair our ...

John Squires’ IP monetisation history offers clues to his interests, but supporters say his focus on business and innovation ...

29 October 2024 A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an ...

As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely ...

The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of litigation in both ...

Return-to-office orders, redundancies, hiring freezes—do changes sweeping through the US agency ‘risk breaking the system’?

13 February 2025 Nominations open as D&I values face growing backlash on both sides of the pond | Research shows equality ...

New York biotech scores win as Fed Circ upholds preliminary injunction against Celltrion's biosimilar launch | Ruling follows ...

The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...

The evolution of WIPR Leaders is an ongoing process, with the 2025 edition setting a new standard that will continue to rise ...